Expert Opinion on Drug Safety, Volume 14, Issue 2 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 14, Issue 2 (2015)

See all volumes and issues
Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Volume 14, 2015 Vol 13, 2014 Vol 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002
Download citations Download PDFs Download issue

Editorial

Editorial
Why are anti-obesity drugs stigmatized?
Bruno Halpern MD & Alfredo Halpern MD PhD
Pages: 185-189
Published online: 20 Dec 2014
AbstractforWhy are anti-obesity drugs stigmatized? | Full Text | References | PDF (170.2 KB)
  • 3259 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Original Research

Article
Reporting patterns of adverse drug reactions over recent years in China: analysis from publications
Xiao-jing Guo, Xiao-fei Ye, Xing-xing Wang, Jing Wang, Wen-tao Shi, Qing-bin Gao, Tian-yi Zhang, Jin-fang Xu, Tian-tian Zhu & Jia He (Professor)
Pages: 191-198
Published online: 06 Jan 2015
AbstractforReporting patterns of adverse drug reactions over recent years in China: analysis from publications | Full Text | References | PDF (363.2 KB)
  • 258 Views
  • 16 CrossRef citations
  • 0Altmetric
Article
Brain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine
Kotaro Hiraoka, Manabu Tashiro, Thomas Grobosch, Marcus Maurer, Keiichi Oda, Jun Toyohara, Kenji Ishii, Kiichi Ishiwata & Kazuhiko Yanai MD PhD
Pages: 199-206
Published online: 03 Dec 2014
AbstractforBrain histamine H1 receptor occupancy measured by PET after oral administration of levocetirizine, a non-sedating antihistamine | Full Text | References | PDF (488.2 KB)
  • 1145 Views
  • 26 CrossRef citations
  • 0Altmetric

Review

Potential side effects to GLP-1 agonists: understanding their safety and tolerability
Agostino Consoli (Professor) MD & Gloria Formoso MD PhD
Pages: 207-218
Published online: 12 Dec 2014
AbstractforPotential side effects to GLP-1 agonists: understanding their safety and tolerability | Full Text | References | PDF (303.4 KB)
  • 1169 Views
  • 36 CrossRef citations
  • 0Altmetric
Do antipsychotics increase diabetes risk in children and adolescents?
Britta Galling & Christoph U Correll
Pages: 219-241
Published online: 05 Dec 2014
AbstractforDo antipsychotics increase diabetes risk in children and adolescents? | Full Text | References | PDF (333.3 KB)
  • 644 Views
  • 24 CrossRef citations
  • 0Altmetric
Safety of off-label biologicals in systemic lupus erythematosus
Martin Aringer & Josef S Smolen
Pages: 243-251
Published online: 06 Dec 2014
AbstractforSafety of off-label biologicals in systemic lupus erythematosus | Full Text | References | PDF (244.7 KB)
  • 862 Views
  • 9 CrossRef citations
  • 0Altmetric
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy
Giuseppe Bronte, Enrico Bronte, Giuseppina Novo, Gianfranco Pernice, Francesca Lo Vullo, Emmanuela Musso, Fabrizio Bronte, Eliana Gulotta, Sergio Rizzo, Christian Rolfo, Nicola Silvestris, Viviana Bazan, Salvatore Novo & Antonio Russo (Professor) MD PhD
Pages: 253-267
Published online: 13 Dec 2014
AbstractforConquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy | Full Text | References | PDF (485.6 KB)
  • 692 Views
  • 40 CrossRef citations
  • 0Altmetric
Proton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events
Robert MacLaren (Professor) PharmD MPH FCCM FCCP, Lynn E Kassel (Clinical Assistant Professor) PharmD, Tyree H Kiser (Associate Professor) PharmD & Douglas N Fish (Professor) PharmD FCCM FCCP
Pages: 269-280
Published online: 25 Nov 2014
AbstractforProton pump inhibitors and histamine-2 receptor antagonists in the intensive care setting: focus on therapeutic and adverse events | Full Text | References | PDF (289.4 KB)
  • 725 Views
  • 13 CrossRef citations
  • 0Altmetric
Therapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease
Manuela Pilleri MD & Angelo Antonini MD
Pages: 281-294
Published online: 06 Dec 2014
AbstractforTherapeutic strategies to prevent and manage dyskinesias in Parkinson’s disease | Full Text | References | PDF (472.4 KB)
  • 817 Views
  • 38 CrossRef citations
  • 0Altmetric
Cardiac risks associated with antibiotics: azithromycin and levofloxacin
Zhiqiang Kevin Lu PhD, Jing Yuan BPharm, Minghui Li MS, S Scott Sutton PharmD, Gowtham A Rao PhD, Sony Jacob MD & Charles L Bennett MD PhD MPP
Pages: 295-303
Published online: 10 Dec 2014
AbstractforCardiac risks associated with antibiotics: azithromycin and levofloxacin | Full Text | References | PDF (220.5 KB)
  • 717 Views
  • 54 CrossRef citations
  • 0Altmetric
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications
Bruno Halpern MD & Alfredo Halpern MD PhD
Pages: 305-315
Published online: 07 Jan 2015
AbstractforSafety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications | Full Text | References | PDF (286.9 KB)
  • 985 Views
  • 24 CrossRef citations
  • 0Altmetric

Drug Safety Evaluation

Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines
James F Davidson (Fellow) MD, James F Donohue (Professor of Medicine) MD & Jill A Ohar (Professor of Medicine) MD
Pages: 317-324
Published online: 17 Jan 2015
AbstractforUmeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelines | Full Text | References | PDF (294.9 KB)
  • 550 Views
  • 0 CrossRef citations
  • 0Altmetric
Drug safety assessment of oral formulations of ketoconazole
Aditya K Gupta MD PhD FRCP(C), Deanne Daigle MSc & Kelly A Foley PhD
Pages: 325-334
Published online: 20 Nov 2014
AbstractforDrug safety assessment of oral formulations of ketoconazole | Full Text | References | PDF (280.5 KB)
  • 532 Views
  • 37 CrossRef citations
  • 0Altmetric
Tigecycline: a critical safety review
Quanhathai Kaewpoowat MD & Luis Ostrosky-Zeichner MD FACP FIDSA FSHEA
Pages: 335-342
Published online: 25 Dec 2014
AbstractforTigecycline: a critical safety review | Full Text | References | PDF (266.7 KB)
  • 1058 Views
  • 64 CrossRef citations
  • 0Altmetric

Further Readings

Related articles
Page: 1
Published online: 17 Jan 2015
CitationforRelated articles | Full Text | PDF (83.6 KB)
  • 38 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles